Ascentage Pharma Group International (AAPG) Total Current Liabilities (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Total Current Liabilities for 3 consecutive years, with $231.7 million as the latest value for Q4 2025.
- For Q4 2025, Total Current Liabilities rose 42.67% year-over-year to $231.7 million; the TTM value through Dec 2025 reached $231.7 million, up 42.67%, while the annual FY2025 figure was $235.0 million, 47.04% up from the prior year.
- Total Current Liabilities hit $231.7 million in Q4 2025 for Ascentage Pharma Group International, up from $162.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $231.7 million in Q4 2025 and bottomed at $129.7 million in Q4 2023.
- Average Total Current Liabilities over 3 years is $174.6 million, with a median of $162.4 million recorded in 2024.
- Year-over-year, Total Current Liabilities grew 25.18% in 2024 and then surged 42.67% in 2025.
- Ascentage Pharma Group International's Total Current Liabilities stood at $129.7 million in 2023, then increased by 25.18% to $162.4 million in 2024, then soared by 42.67% to $231.7 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $231.7 million, $162.4 million, and $129.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.